Search

Avita Therapeutics Inc

Chiusa

15.37 -1.03

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

15.25

Massimo

15.65

Metriche Chiave

By Trading Economics

Entrata

2.9M

-7.7M

Vendite

2.5M

22M

EPS

-0.25

Margine di Profitto

-35.31

Dipendenti

226

EBITDA

3M

-5.6M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

-12.67% downside

Dividendi

By Acuity

Utili prossimi

5 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

327M

469M

Apertura precedente

16.4

Chiusura precedente

15.37

Avita Therapeutics Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

1 nov 2026, 23:51 UTC

South Korea's October Manufacturing PMI Release on November 2 Expected to Reflect Mixed Sentiment Amid Global Economic Pressures.

1 nov 2026, 23:51 UTC

Australia's Building Permits MoM data for September 2026 expected to rise by 2.1% amid cautious market sentiment and ongoing economic pressures.

1 nov 2026, 23:51 UTC

Upcoming ISM Manufacturing Employment Report on November 2, 2026, Expected to Reflect Cautious Sentiment Amid Global Economic Uncertainties.

1 nov 2026, 23:11 UTC

Macro News
Correlated Moves

Gold prices are advancing, supported by rising crude oil prices and increased investor interest in safe-haven assets amid geopolitical tensions in the Middle East.

1 nov 2026, 23:11 UTC

Macro News
Correlated Moves

Silver prices are advancing amid rising crude oil prices and geopolitical tensions, as investors seek safe-haven assets in response to global equity market declines.

1 nov 2026, 23:11 UTC

Brazil's Industrial Production Expected to Decline by 0.2% in September Amid Economic Concerns

1 nov 2026, 23:11 UTC

Australia's Balance of Trade Expected to Show AUD 1.2 Billion Surplus for September Amid Global Economic Uncertainties

1 nov 2026, 23:11 UTC

Macro News

The Dow Jones Industrial Average is advancing today, recovering from Friday's selloff amid geopolitical tensions and rising oil prices, despite earlier session pullbacks.

1 nov 2026, 23:11 UTC

Macro News

The S&P 500 Index is modestly higher despite significant declines in global equity markets and rising oil prices amid geopolitical tensions in the Middle East.

1 nov 2026, 23:11 UTC

Macro News

Natural gas prices are advancing sharply amid rising crude oil prices and fears of supply disruptions linked to ongoing conflicts involving Iran.

1 nov 2026, 23:11 UTC

The EUR/JPY is trading higher at the start of the new week, despite broader market apprehension following a significant U.S. stock selloff on Friday.

1 nov 2026, 23:11 UTC

Macro News
Correlated Moves

Platinum is trading modestly higher as crude oil prices surge amid supply disruption fears linked to ongoing conflicts in the Middle East.

1 nov 2026, 23:11 UTC

Macro News

The Nasdaq 100 Index is advancing, showing a modest increase despite significant declines in global equity markets amid rising oil prices and geopolitical tensions.

1 nov 2026, 23:11 UTC

Macro News

The Russell 2000 Index is modestly higher, gaining ground despite significant declines in major U.S. indices amid rising oil prices and geopolitical tensions.

1 nov 2026, 23:01 UTC

Macro News

The Australian dollar is under pressure amid rising fuel prices and potential $700 million losses at Alaska Air, showing weakness in early trading.

1 nov 2026, 23:01 UTC

The GBP/AUD is advancing as the new trading week begins, showing resilience amid recent volatility in U.S. equity markets.

1 nov 2026, 23:01 UTC

The EUR/AUD is advancing in early trading as the new week begins, following a flat performance since Friday's close.

1 nov 2026, 23:01 UTC

The EUR/CZK is advancing in early trading, showing a slight uptick since Friday's close amid a cautious investor outlook following U.S. market volatility.

1 nov 2026, 23:01 UTC

The EUR/PLN is advancing in early trading this week, positioned near the upper end of its one-month range amid broader market volatility.

1 nov 2026, 22:51 UTC

UK MPC Meeting Minutes on November 5, 2026: Investors Brace for Insights on Interest Rate Changes Amid Rising Inflation and Geopolitical Tensions.

1 nov 2026, 22:31 UTC

Mexican Consumer Confidence Index Set for November 4 Release Amid Ongoing Economic Concerns and Weak Sentiment.

1 nov 2026, 22:11 UTC

Mexico's Business Confidence Data Release on November 3, 2026 Expected to Show Continued Pessimism Amidst Stagnant Manufacturing Trends.

1 nov 2026, 22:11 UTC

Brazil's Central Bank to announce interest rate decisions on November 3, 2026, amid cautious economic sentiment and inflation concerns.

1 nov 2026, 22:01 UTC

Mortgage Rates Decline to 7.37%, Offering Hope for Homebuyers Amid High Prices and Cautious Market Sentiment Ahead of November Data Release

1 nov 2026, 21:41 UTC

Turkey's Balance of Trade Data Release on November 4 Expected to Highlight Ongoing Trade Deficit Amid Economic Optimism and Geopolitical Tensions.

1 nov 2026, 21:41 UTC

Australia's Ai Group Industry Index set for release on November 3 amid cautious market expectations following a significant decline and ongoing investor concerns in the tech sector.

1 nov 2026, 21:31 UTC

Euro Area Retail Sales Expected to Decline by 0.1% Amid Economic Uncertainty and Rising Inflation, with Implications for GDP Growth and Monetary Policy

1 nov 2026, 21:31 UTC

France's Industrial Production MoM data for September 2026 set to release on November 5, with a cautious market anticipating only a modest increase of 0.5% amid rising borrowing costs and negative fiscal outlook.

1 nov 2026, 21:31 UTC

France's Trade Deficit Expected at €5.8 Billion Amid Negative Outlook and Economic Concerns Ahead of November 6 Report

1 nov 2026, 21:31 UTC

Italy's Retail Sales MoM report on November 5 forecasts a modest 0.2% increase amid fluctuating consumer spending trends and inflationary pressures.

Confronto tra pari

Modifica del prezzo

Avita Therapeutics Inc Previsione

Obiettivo di Prezzo

By TipRanks

-12.67% in calo

Previsioni per 12 mesi

Media 13.667 USD  -12.67%

Alto 15 USD

Basso 12 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Avita Therapeutics Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

3 ratings

3

Acquista

0

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
help-icon Live chat